Grant: Discovery Grants Program - Individual
University of Alberta
$72,000.00
Regulation of RNA interference pathways by extracellular cues
FY 2023-24
Summary
Cells whether they be prokaryotic or eukaryotic, must be able to respond appropriately to changes in their environments. This often entails the capacity to alter the mRNA and protein profiles within the cells by modulating gene transcription and/or translation of mRNAs. RNA interference (RNAi) is a gene regulatory mechanism that provides eukaryotic cells with yet another level of control to regulate transcriptomes and proteomes by targeting Argonaute (Ago) proteins to mRNAs via complementary microRNAs. It is estimated that up to 60% of all mammalian protein-encoding genes are regulated by RNAi. Though much is known about the components of the RNAi pathway itself, and the mechanisms by which it carries out gene-silencing, its regulation is comparatively less well understood. We have carried out screens to identify regulators of RNAi pathways and discovered that kinases, and in particular, receptor tyrosine kinases, are significantly over-represented among the negative regulators of RNAi. For example, activation of receptors for epidermal growth factor and fibroblast growth factor (FGF) significantly inhibit RNAi activity. Preliminary findings suggest that other cell surface receptors including those involved in programmed cell death and the inflammatory response downregulate RNAi potentially through a similar mechanism. FGF-mediated inhibition of RNAi was correlated with increased phosphorylation of serine residues in Argonaute 2 (Ago2) protein, a central component of the RNA-induced silencing complex. The underling hypothesis for this proposal is that receptor activation by extracellular stimuli including growth factors and cytokines alter cellular proteomes by changing the miRNA profile, destabilising Ago complexes and re-programming with nascent miRNAs to selectively regulate translation of mRNAs. This likely occurs in part by activation of downstream protein kinases that act upon Ago2 affecting its activity and/or ability to interact with small RNAs. Most of the studies will be done using fibroblast growth factor receptors (FGFRs) as our model system but other receptors will be investigated as required. Our current research objectives will address how: 1.FGFR receptor signaling downregulates RNAi activity The following sub-aims will be pursued. 1.1 -Identifying the signaling cascade(s) linking FGFR signaling to inhibition of Ago2 1.2 -Mapping residues on Ago2 that are phosphorylated in response to FGFR activation 1.3 -Identifying the cellular kinases that act on Ago2 1.4 -Investigating how decreased RNAi activity correlates to Ago2 phosphorylation 2.FGFR and other receptor signaling affects miRNA profiles and loading of Ago2 complexes The following sub-aims will be pursued. 2.1 Determine how miRNA profiles are altered by FGFR signaling 2.2 Determine how RISC-associated miRNAs are affected by FGFR signaling 2.3 Identifying other cellular ligands affecting RNAi pathway
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2019-04411
Name nom
Hobman, Tom
Department département
Cell Biology
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2019
Award amount
72000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Not available
Research subject en
Non disponible
Research subject fr
Non disponible
Application title
Regulation of RNA interference pathways by extracellular cues
Keyword
Argonaute proteins; Cell surface receptors; Dicer; High throughput screens; microRNAs; Receptor tyrosine kinases; Signal transduction
Application summary
Cells whether they be prokaryotic or eukaryotic, must be able to respond appropriately to changes in their environments. This often entails the capacity to alter the mRNA and protein profiles within the cells by modulating gene transcription and/or translation of mRNAs. RNA interference (RNAi) is a gene regulatory mechanism that provides eukaryotic cells with yet another level of control to regulate transcriptomes and proteomes by targeting Argonaute (Ago) proteins to mRNAs via complementary microRNAs. It is estimated that up to 60% of all mammalian protein-encoding genes are regulated by RNAi. Though much is known about the components of the RNAi pathway itself, and the mechanisms by which it carries out gene-silencing, its regulation is comparatively less well understood. We have carried out screens to identify regulators of RNAi pathways and discovered that kinases, and in particular, receptor tyrosine kinases, are significantly over-represented among the negative regulators of RNAi. For example, activation of receptors for epidermal growth factor and fibroblast growth factor (FGF) significantly inhibit RNAi activity. Preliminary findings suggest that other cell surface receptors including those involved in programmed cell death and the inflammatory response downregulate RNAi potentially through a similar mechanism. FGF-mediated inhibition of RNAi was correlated with increased phosphorylation of serine residues in Argonaute 2 (Ago2) protein, a central component of the RNA-induced silencing complex. The underling hypothesis for this proposal is that receptor activation by extracellular stimuli including growth factors and cytokines alter cellular proteomes by changing the miRNA profile, destabilising Ago complexes and re-programming with nascent miRNAs to selectively regulate translation of mRNAs. This likely occurs in part by activation of downstream protein kinases that act upon Ago2 affecting its activity and/or ability to interact with small RNAs. Most of the studies will be done using fibroblast growth factor receptors (FGFRs) as our model system but other receptors will be investigated as required. Our current research objectives will address how: 1.FGFR receptor signaling downregulates RNAi activity The following sub-aims will be pursued. 1.1 -Identifying the signaling cascade(s) linking FGFR signaling to inhibition of Ago2 1.2 -Mapping residues on Ago2 that are phosphorylated in response to FGFR activation 1.3 -Identifying the cellular kinases that act on Ago2 1.4 -Investigating how decreased RNAi activity correlates to Ago2 phosphorylation 2.FGFR and other receptor signaling affects miRNA profiles and loading of Ago2 complexes The following sub-aims will be pursued. 2.1 Determine how miRNA profiles are altered by FGFR signaling 2.2 Determine how RISC-associated miRNAs are affected by FGFR signaling 2.3 Identifying other cellular ligands affecting RNAi pathway